KCT0007752招募中未知
The Real World Effectiveness of Single Inhaler Triple Treatment through Assorted Respiratory Outcomes when Switched from Multiple Inhaler Triple Therapies (RESTART study)
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 107
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational Study
入排标准
- 年龄范围
- 39(Year) 至 o Limit（—）
- 性别
- All
入选标准
- •. Patients older than 40 years of age
- •-. Diagnosed with Chronic obstructive pulmonary disease
- •-. Agree with Participating Research
- •-. Treated by MITT(Multiple Inhaler Triple Treatment),(>=90days)
排除标准
- •- a potentially pregnant patient
- •- Patients who are likely to die within 6 months or have poor health.
- •- Patients with unstable COPD with exacerbation within 4 weeks.
- •- Patients with other illnesses or mental illnesses.
- •- Patients who are hypersensitive to steroids and anti-choline, muscarinic drugs, and lactose/lactose proteins.
- •- Patients who use oral steroids for a long period of time (over 4 weeks) due to diseases other than COPD.
- •- Patients currently participating in interventional clinical research.
研究者
相似试验
招募中
4 期
Efficacy and safety of once-daily single-Inhaler TRiple (Trelegy Ellipta) therApy for Japanese with mild to moderate COPD in Kyushu (TRACK study)Mild to moderate COPDCOPDJPRN-jRCTs071210124Hiromasa Inoue668
招募中
不适用
Efficacy and safety of once-daily single-Inhaler TRiple(Trelegy Ellipta) therApy for Japanese with mild to moderate COPD in KyushuChronic obstructive pulmonary disease (COPD)JPRN-UMIN000046812Kagoshima university668
尚未招募
不适用
sefulluness of single inhalaer treatment with long acting muscarinic antagonist, long acting beta agosit, and inhaled corticosteroid in symptomatic patients with chronic obstructive pulmonary disease without asthma and exacerbatioChronic obstructive pulmonary diseaseJPRN-UMIN000039915Hamamatsu Rosai Hospital15
进行中（未招募）
1 期
Comparación del tratamiento con un único inhalador de Symbicort (Symbicort Turbuhaler 160/4,5 mg, 1 inhalación 2 veces/día como dosis de mantenimiento, y a demanda para el alivio de los síntomas, SMART) con la mejor práctica convencional en el tratamiento del asma persistente en adultos: estudio multicéntrico aleatorizado abierto, de grupos paralelos y 26 semanas de duración. Estudio SPAIN - Estudio SPAIEUCTR2005-005974-64-ESAstraZeneca Farmacéutica Spain, S.A.
招募中
不适用
Comparative study on effectiveness of inhaler treatment for elderly patients with asthma-Chronic Obstructive Pulmonary Disease (COPD) overlap syndrome (ACOS)Diseases of th respiratory systemKCT0002050Asan Medical Center300